Loading company…
India molecular diagnostics company founded in 2010, maker of the portable Truenat PCR platform for infectious diseases.
Founded in 2010 in India, Molbio Diagnostics Pvt. Ltd. develops molecular diagnostics, mainly through its Truenat platform, a portable real-time PCR device for diseases such as tuberculosis, influenza, dengue, malaria and hepatitis. The Truenat technology has affected over 40 million lives in more than 85 countries, with sales mainly to healthcare institutions and government agencies. The company reported revenue of USD 41.42 mn and EBITDA of USD 5.82 mn in 2023. On September 26, 2022, it raised USD 85 mn led by Temasek Holdings and Motilal Oswal Private Equity Advisors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in